Global Dental Membranes and Bone Graft Substitutes Market, by Product Type (Dental Membranes (Resorbable and Non-resorbable) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft (Bovine Xenograft and Porcine Xenograft), and Synthetic Bone Graft Substitutes)), by Material Type (Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite, Tricalcium Phosphate, and Polytetrafluoroethylene), by End User (Hospitals, Dental Clinics, and Ambulatory Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 745.0 million in 2018 and is projected to exhibit a CAGR of 9.1% over the forecast period (2019 – 2027), as highlighted in a new report published by Coherent Market Insights.

The increasing incidence of oral diseases and new product launches by market players is expected to augment the market growth

The increasing prevalence of oral health diseases such as cavities and gum disease is a leading factor driving growth of the dental membranes and bone graft substitutes market across the globe. The factors leading to oral health issues include unhealthy diet, tobacco use, excess alcohol consumption, and poor oral hygiene. For instance, according to FDI World Dental Federation’s Oral Health Atlas published in 2015, oral disease affects around 3.9 billion people worldwide, with untreated tooth decay impacting around 44.0% of the world’s population.

Key players in the market are focused on expanding their product portfolio through strategic collaborations and new product launches. For instance, in February 2019, Zimmer Biomet launched OsseoGuard non-resorbable membrane product line as part of its dental product portfolio.

Furthermore, in April 2017, Zimmer Biomet entered into a distribution agreement with NovaBone Product LLC. According to the agreement, Zimmer Biomet will distribute NovaBone Product LLC’s products through its dental division in over 40 countries in Africa, Middle East, Latin America, Asia Pacific, and selected markets in Europe.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/dental-membrane-and-bone-graft-substitute-market-1143

The increasing technological advancements in the field of material designing for efficient bone regeneration is also expected to boost the market growth. For instance, in 2019, according to researcher at the University of Massachusetts Lowell’s Department of Chemical Engineering, eggshell particles reinforce gelatin-based hydrogels for more stable growth of bone cells. The technology can be utilized in dental implants for bone regeneration.

Browse 31 Market Data Tables and 24 Figures spread through 199 Pages and in-depth TOC on ‘Dental Membranes and Bone Graft Substitutes Market, by Product Type (Dental Membranes (Resorbable and Non-resorbable) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft (Bovine Xenografts and Porcine Xenografts), and Synthetic Bone Graft Substitutes)), by Material Type (Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite, Tricalcium Phosphate, and Polytetrafluoroethylene), by End User (Hospitals, Dental Clinics, and Ambulatory Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027’

The increasing incidence of oral cancer is expected to drive the market growth. For instance, according to World Cancer Research Fund International (WCRF International) reports, in 2018, the global incidence of oral cancer was 354,864 (2.1%) among all the cancers.

Key players in the market are focused on adopting strategies such as partnerships and acquisitions to expand their product portfolio and geographical positioning in the global dental membranes and bone graft substitutes market. For instance, in October 2017, Citagenix, Inc. entered into a distribution agreement with Darby Dental for supply of premium bone grafting and tissue regeneration products in the U.S.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1143

Key Takeaways of the Dental Membranes and Bone Graft Substitutes Market:

The global dental membranes and bone graft substitutes market is expected to exhibit a CAGR of 9.1% over the forecast period, owing to increasing incidence of periodontal diseases and oral cancer. Periodontal disease is a major public health problem in emerging and developed economies of the world. According to the American Academy of Periodontology reports, around 42.0% of adults in the U.S. were diagnosed with periodontitis during 2017.

Among product type, the dental membranes segment held a dominant position in the global dental membranes and bone graft substitutes market in 2017, owing to increasing product approvals in major developed and emerging regions across the globe. For instance, in October 2018, Geistlich Pharma North America Inc. launched alternative soft tissue graft, Geistlich Fibro-Gide, in its portfolio of collagen matrices. It is ideally suited for soft-tissue augmentation around natural teeth and implants.

Among material type, the human cells source segment held dominant position in the global dental membranes and bone graft substitutes market in 2017, owing to new product launches. For instance, in October 2017, LifeNet Health launched PliaFX Strip allograft for dental and bone healing. The product provides high efficiency. PliaFX is composed of cortical bone fibers.

Among end user, the dental clinics segment held a dominant position in the dental membranes and bone graft substitutes market in 2017, owing to increasing number of dentists and dental clinics. For instance, in 2017, according to the American Dental Association, the total number of dentists in the U.S. was around 198,517, which is equivalent to 61 dentists per 100,000 individuals.

Key players operating in the global dental membranes and bone graft substitutes market include Zimmer Biomet Holdings, Inc., Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, Inc., LifeNet Health, RTI Surgical Holdings, Inc., Institut Straumann AG, Dentsply Sirona Inc., and Citagenix, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1143

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737